3 independently sourced, verified trend briefs about this subject.
Newsylist includes a story here only after at least four independent sources support it and its brief passes the verification check. The qualifying coverage spans 1 news category, from Jul 1, 2026 through Jul 27, 2026.
The cards below are ordered newest first. Each opens the underlying timeline, source list, coverage velocity and verification context; raw or extractive-only records are excluded.
New CRISPR gene-editing research indicates a method to improve the immune system's ability to detect and target prostate cancer tumors.
Scientists are investigating how the affordable muscle-building supplement creatine may help fight cancer and enhance immunotherapy.
Researchers are testing a dual-targeting GPNMB CAR-T cell therapy to treat aggressive glioblastoma and its supporting immune cells.